Walter Isaacson on being part of the Pfizer coronavirus vaccine trial

U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Walter Isaacson, Tulane professor and an advisory partner at Perella Weinberg Partners, was part of the trial and he joins "Squawk Box" to discuss his experience as well as the promise of the mRNA technology the vaccine utilizes.
Mon, Nov 9 20209:30 AM EST